1. Solid-Nanoemulsion Preconcentrate for Oral Delivery of Paclitaxel: Formulation Design, Biodistribution, andγScintigraphy Imaging
   Javed Ahmad et al, 2014, BioMed Research International CrossRef
2. Distinct solubility and cytotoxicity regimes of paclitaxel-loaded cationic liposomes at low and high drug content revealed by kinetic phase behavior and cancer cell viability studies
   Victoria M. Steffes et al, 2017, Biomaterials CrossRef
3. Taxane Formulations: From Plant to Clinic
   A. Elhissi et al, 2018 CrossRef
4. Preferential hepatic uptake of paclitaxel-loaded poly-( d - l -lactide- co -glycolide) nanoparticles — A possibility for hepatic drug targeting: Pharmacokinetics and biodistribution
   Dipika Mandal et al, 2018, International Journal of Biological Macromolecules CrossRef
5. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
   Carrie G Lenneman et al, 2016, Circ Res CrossRef
6. In vivo biocompatibility, pharmacokinetics, antitumor efficacy, and hypersensitivity evaluation of ionic liquid-mediated paclitaxel formulations
   Md. Raihan Chowdhury et al, 2019, International Journal of Pharmaceutics CrossRef
7. Current status of nanomedicine in the chemotherapy of breast cancer
   A. I. Fraguas-Sánchez et al, 2019, Cancer Chemother Pharmacol CrossRef
8. Development and evaluation of transferrin-stabilized paclitaxel nanocrystal formulation
   Ying Lu et al, 2014, Journal of Controlled Release CrossRef
9. Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution
   Yong Xu et al, 2016, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
10. Efficient Drug Delivery of Paclitaxel Glycoside: A Novel Solubility Gradient Encapsulation into Liposomes Coupled with Immunoliposomes Preparation
    Tsukasa Shigehiro et al, 2014, PLoS ONE CrossRef
11. Preparation, Pharmacokinetics, Biodistribution, Antitumor Efficacy and Safety of Lx2-32c-Containing Liposome
    Hongbo Wang et al, 2014, PLoS ONE CrossRef
12. Paradoxical rise of hemolytic complement in the blood of mice during zymosan- and liposome-induced CARPA: a pilot study
    Tamás Mészáros et al, 2015 CrossRef
13. Nanotechnology for the delivery of phytochemicals in cancer therapy
    Jing Xie et al, 2016, Biotechnology Advances CrossRef
14. Effect of HM30181 mesylate salt-loaded microcapsules on the oral absorption of paclitaxel as a novel P-glycoprotein inhibitor
    Jin Cheul Kim et al, 2016, International Journal of Pharmaceutics CrossRef
15. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan
    Umesh Gupta et al, 2017, International Journal of Biological Macromolecules CrossRef
16. Self-assembled liposomes of dual paclitaxel-phospholipid prodrug for anticancer therapy
    Longbing Ling et al, 2017, International Journal of Pharmaceutics CrossRef
17. Paclitaxel: What has been done and the challenges remain ahead
    Ezequiel Bernabeu et al, 2017, International Journal of Pharmaceutics CrossRef
18. Taxane anticancer formulations: challenges and achievements
    Abdelbary M.A. Elhissi et al, 2020 CrossRef
19. Efficacy and safety analysis of paclitaxel, docetaxel and liposomal paclitaxel after neoadjuvant therapy in breast cancer
    Zhao Bi et al, 2020, Breast Cancer Res Treat CrossRef
20. Paclitaxel-eluting silicone airway stent for preventing granulation tissue growth and lung cancer relapse in central airway pathologies
    Jesse Xu et al, 2020, Expert Opinion on Drug Delivery CrossRef
21. Pathophysiological mechanisms of cardiotoxicity in chemotherapeutic agents
    Aleksey M. Chaulin et al, 2020, Russ Open Med J CrossRef
22. Physicochemical Characterization of PHBV Nanoparticles Functionalized with Multiple Bioactives Designed to be Theranostics for Lung Cancer
    Paula Solar et al, 2020, J Clust Sci CrossRef
23. Paclitaxel antitumor effect improvement in lung cancer and prevention of the painful neuropathy using large pegylated cationic liposomes
    Julia Jiménez-López et al, 2021, Biomedicine & Pharmacotherapy CrossRef
24. The Use of Phospholipids to Make Pharmaceutical Form Line Extensions
    Peter Hoogevest et al, 2021, Eur. J. Lipid Sci. Technol. CrossRef
25. Bioactive nanotherapeutic trends to combat triple negative breast cancer
    Pallabita Chowdhury et al, 2021, Bioactive Materials CrossRef
26. Recent Advances of Taxol-Loaded Biocompatible Nanocarriers Embedded in Natural Polymer-Based Hydrogels
    Silvia Voci et al, 2021, Gels CrossRef
27. The length of disulfide bond-containing linkages impacts the oral absorption and antitumor activity of paclitaxel prodrug-loaded nanoemulsions
    Yanlin Gao et al, 2021, Nanoscale CrossRef
28. Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations
    Jun Ye et al, 2021, J Nanobiotechnol CrossRef
29. Taxanes loaded polymersomes as an emerging polymeric nanocarrier for cancer therapy
    Vanshikha Singh et al, 2021, European Polymer Journal CrossRef
30. The Application of Nanoparticles in Diagnosis and Treatment of Kidney Diseases
    Patrycja Paluszkiewicz et al, 2021, IJMS CrossRef
31. Paclitaxel Drug Delivery Systems: Focus on Nanocrystals’ Surface Modifications
    Razan Haddad et al, 2022, Polymers CrossRef
32. Current status of nanomedicine for breast cancer treatment
    A.I. Fraguas-Sanchez et al, 2022 CrossRef
33. A systemic review of taxanes and their side effects in metastatic breast cancer
    Jiun-I. Lai et al, 2022, Front. Oncol. CrossRef
34. Pharmaceutical liposomal delivery—specific considerations of innovation and challenges
    Taoxing Peng et al, 2022, Biomater. Sci. CrossRef
35. Cancer treatment: from traditional Chinese herbal medicine to the liposome delivery system
    Minhan Fu et al, 2022 CrossRef
36. Paclitaxel-Loaded Cationic Fluid Lipid Nanodiscs and Liposomes with Brush-Conformation PEG Chains Penetrate Breast Tumors and Trigger Caspase-3 Activation
    Lorena Simón-Gracia et al, 2022, ACS Appl. Mater. Interfaces CrossRef
37. Functionalized liposomes for targeted breast cancer drug delivery
    Janske Nel et al, 2023, Bioactive Materials CrossRef
38. La prueba de activación de basófilos como ayuda para el diagnóstico y tratamiento de la anafilaxia asociada a un preparado de testosterona
    Felipe Santos-Vicente et al, 2021, RAM CrossRef
39. Study on Modification of Paclitaxel and Its Antitumor Preparation
    null Wenhao Zhou et al, 2023, Russ J Bioorg Chem CrossRef
40. GLUT1 transporter-facilitated solid lipid nanoparticles loaded with anti-cancer therapeutics for ovarian cancer targeting
    Saili Jagdale et al, 2023, International Journal of Pharmaceutics CrossRef
41. A paclitaxel prodrug nanoparticles with glutathion/reactive oxygen species dual‐responsive and CD206 targeting to improve the anti‐tumour effect
    Changhai Wang et al, 2023, IET Nanobiotechnology CrossRef
42. Nanoscale drug delivery systems for cancer therapy using paclitaxel— A review of challenges and latest progressions
    Ghulam Mustafa et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
43. Efficacy comparisons of solvent-based paclitaxel, liposomal paclitaxel, nanoparticle albumin-bound paclitaxel, and docetaxel after neoadjuvant systemic treatment in breast cancer
    Weiwei Zhang et al, 2023, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
44. Advancements and hurdles in the development of a vaccine for triple-negative breast cancer: A comprehensive review of multi-omics and immunomics strategies
    T. Dhanushkumar et al, 2023, Life Sciences CrossRef
45. Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: a multicenter, retrospective real-world study
    Ran Li et al, 2024, BMC Cancer CrossRef
46. Liposomal Drug Delivery: Progress, Clinical Outlook, and Ongoing Challenges
    Chanchal Tiwari et al, 2024, RADDF CrossRef
47. Innovative Nanoscale Drug Delivery Strategies for Breast Carcinoma: A Comprehensive Exploration
    Jaishree S. et al, 2024, CDM CrossRef